Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, 1-1 Fukakusamukaihata-cho, Fushimi-ku, Kyoto, 612-8555, Japan.
Faculty of Humanities and Social Sciences, University of Marketing and Distribution Sciences, Hyogo, Japan.
BMC Res Notes. 2020 Aug 8;13(1):375. doi: 10.1186/s13104-020-05215-x.
Frequent self-weighing is associated with weight loss and maintenance, but the relationship between frequent self-weighing and the incidence of type 2 diabetes (T2D) remains unclear. The study aim was to examine the association between self-weighing frequency and the incidence of T2D in people with impaired fasting glucose (IFG).
We tested the hypothesis that self-weighing frequency and the incidence of T2D are associated in 2607 people with IFG (1240 in the intervention arm; 1367 in the self-directed control arm). Both arms received a weighing scale with storage function. Healthcare providers offered a one-year goal-focused lifestyle intervention via phone. Participants were divided into 4 categories based on self-weighing frequency (No data sent [reference group], low: < 2 times/week, middle: 3-4 times/week, and high: 5-7 times/week). The adjusted hazard ratio (AHR) and 95% confidence interval (CI) were calculated. In the intervention arm, middle- and high-frequency self-weighing were associated with a decreased incidence of T2D relative to the reference group (AHR = 0.56, 95% CI [0.32, 0.98] and AHR = 0.43, 95% CI [0.25, 0.74], respectively). In the control arm, high-frequency self-weighing was also associated with a decreased incidence of T2D relative to the reference group (AHR = 0.54, 95% CI [0.35, 0.83]). Trial registration This trial has been registered with the University Hospital Medical Information Network (UMIN000000662).
频繁自我称重与体重减轻和维持有关,但频繁自我称重与 2 型糖尿病(T2D)的发生之间的关系尚不清楚。本研究旨在检验自我称重频率与空腹血糖受损(IFG)人群 T2D 发生率之间的关系。
我们检验了以下假设,即自我称重频率与 T2D 的发生之间存在关联,在 2607 名 IFG 患者(干预组 1240 例;自我指导对照组 1367 例)中进行了测试。两组均配备具有存储功能的体重秤。医疗保健提供者通过电话提供为期一年的以目标为导向的生活方式干预。根据自我称重频率将参与者分为 4 组(无数据发送[参考组]、低:<2 次/周、中:3-4 次/周、高:5-7 次/周)。计算了调整后的风险比(AHR)和 95%置信区间(CI)。在干预组中,与参考组相比,中、高频率自我称重与 T2D 发生率降低相关(AHR=0.56,95%CI[0.32,0.98]和 AHR=0.43,95%CI[0.25,0.74])。在对照组中,与参考组相比,高频率自我称重也与 T2D 发生率降低相关(AHR=0.54,95%CI[0.35,0.83])。
本试验已在大学医院医疗信息网络(UMIN000000662)注册。